Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
T3D Therapeutics
company
About
T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.
- Durham,North Carolina,United States
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $6M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- T3D Therapeutics Inc.
T3D Therapeutics is a developer of a novel drug therapy intended to stop or reverse the course of Alzheimer's disease. The company's drug is an orally-delivered once-a-day medicine that targets both the brain 'starvation' and neurodegeneration of Alzheimer's disease and helps in treating multiple manifestations of the disease, providing Alzheimer patients with a drug to potentially improve multiple defects and improve memory, motor function and cognition.T3D Therapeutics is based in Durham, North Carolina, and was founded in 2013.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
8
$40.31M
T3D Therapeutics has raised a total of
$40.31M
in funding over 2 rounds. Their latest funding was raised on
Sep 3, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 3, 2022 | Series Unknown | $6M | — | — | — | Detail |
| Nov 4, 2019 | Series B | $15M | 1 |
|
— | Detail |
| May 21, 2019 | Grant | $9M | — | — | — | Detail |
| Mar 10, 2018 | Series Unknown | $6M | — | — | — | Detail |
| Mar 11, 2016 | Seed | $1.21M | — | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
T3D Therapeutics is funded by 1 investors.
National Institute on Aging
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
Employee Profiles
Number of Employee Profiles
3
T3D Therapeutics has 3 current employee profiles, including
Executive Warren Strittmatter
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
